Retraction
MicroRNA-802 inhibits epithelial-mesenchymal transition through targeting Flotillin-2 in human prostate cancer
Paper Information
Record ID:
43151
Author(s):
Journal:
Publication Date:
April 30, 2017
Retraction Date:
March 01, 2023
(2.7 years years ago)
Subjects:
Institution:
Department of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Portland Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1042/BSR-2016-0521_RETAdditional Notes:
see also: https://pubpeer.com/publications/58E895753C3A7B4F82B3F8C665AEEF
Citations (31)
31
Total Citations0
Post-Retraction31
Pre-Retraction0
Same DayIdentification of Hub Genes in Prostate Cancer by Bioinformatics Analysis
Rui Zhang, Wenhua Guo, Luhong Yang
OALib
Open Access
Published: Jan 2023
1 citation
1 citation
59 days before retraction
An Overview on the Pathophysiological Roles of microRNA- 802: a Literature Review
Maryam Eini, Jafar Kiani, Elahe Seyed Hosseini et al. (8 authors)
Biointerface Research in Applied Chemistry
Open Access
Published: Mar 2022
1 citation
1 citation
336 days before retraction
MetastamiRs: The Role of MicroRNAs in the Metastatic Phenotype of Prostate Cancer
Adam Wiggins, Jonathan Xu, Aaron Perecman et al. (7 authors)
Exon Publications eBooks
Open Access
Published: Mar 2022
352 days before retraction
Bioinformatic Investigation of Micro RNA-802 Target Genes, Protein Networks, and Its Potential Prognostic Value in Breast Cancer
Maryam Eini, Sepideh Parsi, Mahmood Barati et al. (8 authors)
Avicenna Journal of Medical Biotechnology
Open Access
Published: Mar 2022
4 citations
4 citations
354 days before retraction
Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways
Jiahui Wei, Ruiqing Wang, Yiran Lu et al. (5 authors)
European Journal of Pharmacology
Published: Nov 2021
14 citations
14 citations
474 days before retraction
Dysfunction of miR‐802 in tumors
Tong Gao, Mengsha Zou, Tiancheng Shen et al. (4 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Sep 2021
22 citations
22 citations
523 days before retraction
Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment
Su Jung Oh‐Hohenhorst, Tobias Lange
Cancers
Open Access
Published: Sep 2021
46 citations
46 citations
541 days before retraction
A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer
James J. Saller, Kun Jiang, Yin Xiong et al. (10 authors)
Digestive Diseases and Sciences
Open Access
Published: Mar 2021
5 citations
5 citations
718 days before retraction
Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients
Martyna Parol‐Kulczyk, Arkadiusz Gzil, Magdalena Bodnar et al. (4 authors)
Journal of Translational Medicine
Open Access
Published: Jan 2021
18 citations
18 citations
783 days before retraction
Identification of MYLIP gene and miRNA-802 involved in the growth and metastasis of cervical cancer cells
Ming Ni, Yan Qin, Hui Xue et al. (6 authors)
Cancer Biomarkers
Published: Nov 2020
18 citations
18 citations
838 days before retraction
<p>MicroRNA-802 Suppresses Tumorigenesis of Colorectal Cancer via Regulating UBN2</p>
Tao Yang, Qiuying Guo, Dongsheng Li et al. (6 authors)
Cancer Management and Research
Open Access
Published: Nov 2020
8 citations
8 citations
850 days before retraction
Flotillin membrane domains in cancer
Cécile Gauthier‐Rouvière, Stéphane Bodin, Franck Comunale et al. (4 authors)
Cancer and Metastasis Reviews
Open Access
Published: Apr 2020
61 citations
61 citations
1050 days before retraction
Regulation of the small GTPase Ran by miR-802 modulates proliferation and metastasis in colorectal cancer cells
Xin Wang, Danxiu Li, Lina Sun et al. (20 authors)
British Journal of Cancer
Open Access
Published: Mar 2020
12 citations
12 citations
1071 days before retraction
<p>MiR-802 Suppresses Colorectal Cancer Cell Viability, Migration and Invasion by Targeting RAN</p>
Hai‐Long Feng, Lingling Liu, Laijing Xu et al. (6 authors)
Cancer Management and Research
Open Access
Published: Mar 2020
13 citations
13 citations
1095 days before retraction
Flotillin‑2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
Zhiying Xu, Tao Wang, Haiyang Song et al. (4 authors)
Oncology Letters
Open Access
Published: Jan 2020
6 citations
6 citations
1132 days before retraction
Downregulation of circulating miR 802‐5p and miR 194‐5p and upregulation of brain MEF2C along breast cancer brain metastasization
Marta Sereno, János Haskó, Kinga Molnár et al. (12 authors)
Molecular Oncology
Open Access
Published: Jan 2020
40 citations
40 citations
1143 days before retraction
MiR-802 alleviates lipopolysaccharide-induced acute lung injury by targeting Peli2
Qinghai You, Jinmei Wang, Dan Jia et al. (6 authors)
Inflammation Research
Open Access
Published: Nov 2019
27 citations
27 citations
1211 days before retraction
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ
Bo Yang, Li Sun, Lei Liang
Journal of Ovarian Research
Open Access
Published: Oct 2019
33 citations
33 citations
1226 days before retraction
MicroRNA‐351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus
Shuhong Chen, Xiao‐Nan Liu, Yan Peng
Journal of Cellular and Molecular Medicine
Open Access
Published: Jul 2019
75 citations
75 citations
1331 days before retraction
High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD1)-Mediated Function of T Cells
Chao Jiang, Xueyan Liu, Meng Wang et al. (5 authors)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Open Access
Published: Apr 2019
18 citations
18 citations
1416 days before retraction
miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1
Jiexia Zhang, Jun Li, Shiyue Li et al. (6 authors)
International Journal of Oncology
Open Access
Published: Mar 2019
13 citations
13 citations
1433 days before retraction
The effects of growth hormone on therapy resistance in cancer
Reetobrata Basu, John J. Kopchick
Cancer Drug Resistance
Open Access
Published: Jan 2019
33 citations
33 citations
1520 days before retraction
MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2
Feng Gao, Hao Wu, Rui Wang et al. (9 authors)
Bioengineered
Open Access
Published: Jan 2019
60 citations
60 citations
1520 days before retraction
microRNA‐802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine‐rich splicing factor 9
Qianwen Zhang, Rui Lv, Wenjia Guo et al. (4 authors)
Journal of Cellular Biochemistry
Published: Dec 2018
47 citations
47 citations
1533 days before retraction
Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
Kira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen et al. (6 authors)
PLoS ONE
Open Access
Published: Nov 2018
40 citations
40 citations
1556 days before retraction
Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B
Jingjing Yu, Wen-Sen Pi, Yuan Cao et al. (9 authors)
Cancer Management and Research
Open Access
Published: Nov 2018
17 citations
17 citations
1581 days before retraction
Vitamin D/VDR signaling suppresses microRNA‐802‐induced apoptosis of keratinocytes in oral lichen planus
Bin Zhao, Na Xu, Ran Li et al. (9 authors)
The FASEB Journal
Published: Aug 2018
35 citations
35 citations
1671 days before retraction
miR‑202 suppresses prostate cancer growth and metastasis by targeting PIK3CA
Shengping Zhang, Jiarong Cai, Wenjun Xie et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Jun 2018
28 citations
28 citations
1723 days before retraction
Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway
Lianmei Zhao, Jie Li, Yueping Liu et al. (10 authors)
Cancer Biology and Medicine
Open Access
Published: Jan 2018
33 citations
33 citations
1885 days before retraction
Implications of microRNA dysregulation in the development of prostate cancer
Cintia Massillo, Guillermo Nicolás Dalton, Paula Lucía Farré et al. (5 authors)
Reproduction
Open Access
Published: Sep 2017
52 citations
52 citations
2001 days before retraction
microRNA-802 is involved in palmitate-induced damage to pancreatic β cells through repression of sirtuin 6.
Ning Lin, Yixin Niu, Weiwei Zhang et al. (6 authors)
PubMed
Published: Jan 2017
5 citations
5 citations
2250 days before retraction
Quick Stats
Total Citations:
31
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025